Edesa Biotech Inc (EDSA)

NASDAQ
Currency in USD
2.5596
+0.0596(+2.38%)
Real-time Data
EDSA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.41002.6000
52 wk Range
1.55005.5900
Key Statistics
Edit
Prev. Close
2.5
Open
2.41
Day's Range
2.41-2.6
52 wk Range
1.55-5.59
Volume
47.51K
Average Volume (3m)
1.98M
1-Year Change
-53.45%
Book Value / Share
0.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EDSA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
20.5000
Upside
+700.91%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Edesa Biotech Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Compare EDSA to Peers and Sector

Metrics to compare
EDSA
Peers
Sector
Relationship
P/E Ratio
−2.9x−1.3x−0.7x
PEG Ratio
−0.10−0.040.00
Price/Book
13.7x−0.1x2.6x
Price / LTM Sales
-35.1x3.1x
Upside (Analyst Target)
-343.5%49.4%
Fair Value Upside
Unlock−4.7%8.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.5000
(+700.91% Upside)

Earnings

Latest Release
Dec 13, 2023
EPS / Forecast
-- / -0.1567
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Edesa Biotech (EDSA) Stock Price Today?

The Edesa Biotech stock price today is 2.5596.

What Stock Exchange Does Edesa Biotech Trade On?

Edesa Biotech is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Edesa Biotech?

The stock symbol for Edesa Biotech is "EDSA."

What Is the Edesa Biotech Market Cap?

As of today, Edesa Biotech market cap is 8.84M.

What is Edesa Biotech Earnings Per Share?

The Edesa Biotech EPS is -1.88.

From a Technical Analysis Perspective, Is EDSA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.